Form 8-K Imprimis Pharmaceuticals For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Imprimis Pharma (IMMY) Misses Q2 EPS by 7c
August 12, 2015 4:49 PM EDTImprimis Pharma (NASDAQ: IMMY) reported Q2 EPS of ($0.39), $0.07 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.13 million.
For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.
... More


